NCT01894412View on ClinicalTrials.gov

Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

BIOLOGICAL

Etanercept (Enbrel)

BIOLOGICAL

HD203

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Hanwha Chemical

All Listed Sponsors

lead

Hanwha Chemical

INDUSTRY